Influence of indomethacin on PGE2 in rabbit aqueous humor after YAG laser photodisruption of the iris.
Skorpik C, Juchem M, Paroussis P, Vierhapper H
AI Summary
Indomethacin eye drops significantly reduced PGE2 levels in rabbit aqueous humor for 12 hours after YAG laser iris disruption. This suggests indomethacin may offer short-term anti-inflammatory benefits post-laser.
Abstract
In an experimental study with rabbits, the influence of indomethacin on the postoperative PGE2 level in the aqueous humor was investigated, following YAG laser traumatization of the iris. Indomethacin is a drug with an inhibitory effect on the synthesis of prostaglandins. Using albino rabbits, the right eye was treated with indomethacin eye drops three times daily for 3 days. On the 4th day, high-energy YAG laser was applied to the iris of both eyes (Q-switched Nd: YAG Laser, Model Cilco Lasertek PV 135; ten photodisruptive lesions, with 50 mJ to the midperiphery of the iris). Subsequently, the rabbits were subdivided into three groups. In group 1 the aqueous humor was removed from both eyes 12 h postoperatively; in group 2 the aqueous humor was tapped 36 h after the intervention; for group 3, it was 60 h afterwards. The results from 15 rabbits were evaluated. Local indomethacin treatment was continued until tapping of the aqueous humor. As a control, another group was used with 3 rabbits without treatment. Twelve hours after YAG laser treatment there was still a clearly significant difference in the PGE2 concentrations between the eyes that had received indomethacin and the untreated eyes; 36 h postoperatively, the difference was no longer statistically significant, and after 60 h the PGE2 concentrations of the treated and untreated eyes were the same.
MeSH Terms
Shields Classification
Related Articles5
Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells.
Basic SciencePresence of mitomycin-C in the anterior chamber after photorefractive keratectomy.
Basic ScienceCollagen degradation in glaucoma: will it gain a therapeutic value?
ReviewInvolvement of the Erk-MAP kinase pathway in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs.
Basic ScienceBrimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
ReviewIs this article assigned to the wrong chapter(s)? Let us know.